BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10413524)

  • 1. Stoichiometry of the interaction between the major histocompatibility complex-related Fc receptor and its Fc ligand.
    Sánchez LM; Penny DM; Bjorkman PJ
    Biochemistry; 1999 Jul; 38(29):9471-6. PubMed ID: 10413524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the complex of rat neonatal Fc receptor with Fc.
    Burmeister WP; Huber AH; Bjorkman PJ
    Nature; 1994 Nov; 372(6504):379-83. PubMed ID: 7969498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the 2:1 complex between the class I MHC-related Fc receptor and its Fc ligand in solution.
    Martin WL; Bjorkman PJ
    Biochemistry; 1999 Sep; 38(39):12639-47. PubMed ID: 10504233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization and stoichiometry of binding of a complex between a rat intestinal Fc receptor and Fc.
    Huber AH; Kelley RF; Gastinel LN; Bjorkman PJ
    J Mol Biol; 1993 Apr; 230(3):1077-83. PubMed ID: 8478919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-affinity binding of the neonatal Fc receptor to its IgG ligand requires receptor immobilization.
    Vaughn DE; Bjorkman PJ
    Biochemistry; 1997 Aug; 36(31):9374-80. PubMed ID: 9235980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of critical IgG binding epitopes on the neonatal Fc receptor.
    Vaughn DE; Milburn CM; Penny DM; Martin WL; Johnson JL; Bjorkman PJ
    J Mol Biol; 1997 Dec; 274(4):597-607. PubMed ID: 9417938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.
    Suzuki T; Ishii-Watabe A; Tada M; Kobayashi T; Kanayasu-Toyoda T; Kawanishi T; Yamaguchi T
    J Immunol; 2010 Feb; 184(4):1968-76. PubMed ID: 20083659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin binding to FcRn: distinct from the FcRn-IgG interaction.
    Chaudhury C; Brooks CL; Carter DC; Robinson JM; Anderson CL
    Biochemistry; 2006 Apr; 45(15):4983-90. PubMed ID: 16605266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor.
    Burmeister WP; Gastinel LN; Simister NE; Blum ML; Bjorkman PJ
    Nature; 1994 Nov; 372(6504):336-43. PubMed ID: 7969491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding.
    Martin WL; West AP; Gan L; Bjorkman PJ
    Mol Cell; 2001 Apr; 7(4):867-77. PubMed ID: 11336709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational determination of the structure of rat Fc bound to the neonatal Fc receptor.
    Weng Z; Gulukota K; Vaughn DE; Bjorkman PJ; DeLisi C
    J Mol Biol; 1998 Sep; 282(2):217-25. PubMed ID: 9735282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualification of a homogeneous cell-based neonatal Fc receptor (FcRn) binding assay and its application to studies on Fc functionality of IgG-based therapeutics.
    Mathur A; Arora T; Liu L; Crouse-Zeineddini J; Mukku V
    J Immunol Methods; 2013 Apr; 390(1-2):81-91. PubMed ID: 23384837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity.
    Abdiche YN; Yeung YA; Chaparro-Riggers J; Barman I; Strop P; Chin SM; Pham A; Bolton G; McDonough D; Lindquist K; Pons J; Rajpal A
    MAbs; 2015; 7(2):331-43. PubMed ID: 25658443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field flow fractionation for assessing neonatal Fc receptor and Fcγ receptor binding to monoclonal antibodies in solution.
    Pollastrini J; Dillon TM; Bondarenko P; Chou RY
    Anal Biochem; 2011 Jul; 414(1):88-98. PubMed ID: 21385563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of new models for the analysis of Fc-FcRn interactions.
    Gurbaxani BM; Morrison SL
    Mol Immunol; 2006 Mar; 43(9):1379-89. PubMed ID: 16183124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta.
    Simister NE; Story CM; Chen HL; Hunt JS
    Eur J Immunol; 1996 Jul; 26(7):1527-31. PubMed ID: 8766556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin.
    Andersen JT; Dee Qian J; Sandlie I
    Eur J Immunol; 2006 Nov; 36(11):3044-51. PubMed ID: 17048273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A strategy for bacterial production of a soluble functional human neonatal Fc receptor.
    Andersen JT; Justesen S; Berntzen G; Michaelsen TE; Lauvrak V; Fleckenstein B; Buus S; Sandlie I
    J Immunol Methods; 2008 Feb; 331(1-2):39-49. PubMed ID: 18155020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1.
    Medesan C; Matesoi D; Radu C; Ghetie V; Ward ES
    J Immunol; 1997 Mar; 158(5):2211-7. PubMed ID: 9036967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FcRn: the neonatal Fc receptor comes of age.
    Roopenian DC; Akilesh S
    Nat Rev Immunol; 2007 Sep; 7(9):715-25. PubMed ID: 17703228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.